CBFAX
Price
$42.52
Change
+$0.31 (+0.73%)
Updated
Sep 17 closing price
Net Assets
33.83B
CIRAX
Price
$82.46
Change
+$0.47 (+0.57%)
Updated
Sep 17 closing price
Net Assets
130.57B
Interact to see
Advertisement

CBFAX vs CIRAX

CBFAX vs CIRAX Comparison Chart in %
View a ticker or compare two or three
VS
CBFAX vs. CIRAX commentary
Sep 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBFAX is a Hold and CIRAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIRAX has more cash in the bank: 131B vs. CBFAX (33.8B). CIRAX pays higher dividends than CBFAX: CIRAX (2.65) vs CBFAX (1.95). CBFAX was incepted earlier than CIRAX: CBFAX (16 years) vs CIRAX (25 years). CBFAX (0.83) is less costly to investors than CIRAX (0.60). CBFAX (50.00) and CIRAX (50.00) have comparable annual turnover. CBFAX (4%) and CIRAX (4%) have equivalent initial investment costs. CBFAX (250) and CIRAX (250) have matching initial minimum investment requirements. CIRAX annual gain was more profitable for investors over the last year : 7.45 vs. CBFAX (5.67). CIRAX return over 5 years is better than : 42.99 vs. CBFAX (16.82).
CBFAXCIRAXCBFAX / CIRAX
Total Expense Ratio0.830.60138%
Annual Report Gross Expense Ratio0.830.60138%
Fund Existence16 years25 years-
Gain YTD6.6009.17472%
Front Load4%4%100%
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets33.8B131B26%
Annual Yield % from dividends1.952.6574%
Returns for 1 year5.677.4576%
Returns for 3 years32.8743.0576%
Returns for 5 years16.8242.9939%
Returns for 10 years69.9696.2773%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OCIEX18.140.18
+1.00%
Optimum International C
FAGCX261.45N/A
N/A
Fidelity Advisor Growth Opps I
HLMOX9.53N/A
N/A
Harding Loevner Frontier Emerg Mkts Inv
SEFCX14.83N/A
N/A
SEI International Equity Y (SIT)
WPCSX40.82N/A
N/A
AB Concentrated Growth C